Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06788769

Study of Clostridioides Difficile in Infants

Retrospective Analysis of Risk Factors and Microbiome Alterations in Infant Clostridioides Difficile Infection

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Westlake University · Academic / Other
Sex
All
Age
1 Day – 2 Years
Healthy volunteers
Not accepted

Summary

Clostridioides difficile infection (CDI) poses an increasing threat to infant and young child health, with detection rates rising annually. This retrospective study aims to explore the epidemiological characteristics, clinical manifestations, and potential biomarkers of CDI in children aged 0-2 years by examining three cohorts: (1) infants diagnosed with CDI, (2) asymptomatic carriers of C. difficile, and (3) healthy controls. Fecal samples from each group will undergo metagenomic sequencing and metabolomic profiling, coupled with questionnaire-based surveys for risk factor assessment. The findings are anticipated to identify key high-risk factors, elucidate the pathogenic mechanisms underlying infant CDI, and support the development of early diagnostic tools and preventive strategies.

Conditions

Timeline

Start date
2024-07-01
Primary completion
2026-08-30
Completion
2026-12-30
First posted
2025-01-23
Last updated
2025-01-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06788769. Inclusion in this directory is not an endorsement.

Study of Clostridioides Difficile in Infants (NCT06788769) · Clinical Trials Directory